Bio

I am a doctoral candidate in the Chemical Biology Program at Harvard University, conducting my thesis research on drug resistance mechanisms in Plasmodium falciparum under the supervision of Dyann Wirth (Harvard T.H. Chan School of Public Health) and Ralph Mazitschek (Massachusetts General Hospital).

My general interest is at the intersection of metabolism and drug resistance, and I have deep experience in applying mass spectrometry to diverse areas of study. I previously worked on developing automated methods for proteomics workflows, including affinity purification for interactomics studies, post-translational modification analysis, and biomarker discovery and verification methods as a biochemist at the Broad Institute. I also have prior experience in vaccine target identification and characterization using proteomic methods and quantitative mass spectrometry for non-proteomic workflows.

I studied Chemistry at Emory College (BS, 2006), Biomedical Science at Rutgers University Graduate School of Biomedical Sciences (MBS, 2009), and Health Systems & Policy at Rutgers University School of Public Health (MPH, 2011).